ET cases had a similar pS6K/S6K ratio as controls (0.88±0.27 vs. 1.00±0.44, p = 0.47), suggesting that the differences in mTOR activity do not directly account for the decreased LC3-II in ET (Figure 3G, H). Here, RPS6KB1 is linked to essential thrombocythemia.